Issued Patents All Time
Showing 1–25 of 32 patents
| Patent # | Title | Co-Inventors | Date |
|---|---|---|---|
| 12371414 | Methods of treating neurological disorders | Paul John Dransfield, Dilinie Fernando, James S. Harvey, Brian Andrew Sparling, John Stellwagen +2 more | 2025-07-29 |
| 12358931 | 3-((1R,3s,5S)-3-((7-((5-methyl-1H-pyrazol-3-yl)amino)-1,6-naphthyridin-5-yl)amino)-8-azabicyclo[3.2.1]octan-8-yl) propanenitrile as a JAK kinase inhibitor | Ryan Hudson, Jennifer Kozak, Paul R. Fatheree, Dante D. Podesto, Gary E. L. Brandt +1 more | 2025-07-15 |
| 12221433 | Acyl sulfonamides that are Bcl family antagonists for use in clinical management of conditions caused or mediated by senescent cells and for treating cancer | Ryan Hudson | 2025-02-11 |
| 11993580 | Methods of treating neurological disorders | Paul John Dransfield, Dilinie Fernando, James S. Harvey, Brian Andrew Sparling, John Stellwagen +2 more | 2024-05-28 |
| 11897874 | Compounds and methods for modulating Interleukin-2-inducible T-cell kinase | Ryan Hudson | 2024-02-13 |
| 11718616 | JAK kinase inhibitor compounds for treatment of respiratory disease | Paul R. Fatheree, John R. Jacobsen, Gary E. L. Brandt, Melissa Fleury, Lan Jiang +9 more | 2023-08-08 |
| 11642332 | (2R,4R)-5-(5′-chloro-2′-fluorobiphenyl-4-yl)-2-hydroxy-4-[(5-methyloxazole-2-carbonyl)amino]pentanoic acid | Melissa Fleury, Adam D. Hughes, Erik Fenster, Venkat R. Thalladi, Miroslav Rapta | 2023-05-09 |
| 11306099 | Compounds and methods for modulating Bruton's Tyrosine Kinase | Ryan Hudson, Richard A. Miller, Erik Verner | 2022-04-19 |
| 11299492 | JAK kinase inhibitor compounds for treatment of respiratory disease | Paul R. Fatheree, John R. Jacobsen, Gary E. L. Brandt, Melissa Fleury, Lan Jiang +3 more | 2022-04-12 |
| 11110095 | Pyrimidine compounds as JAK kinase inhibitors | Ryan Hudson, Jennifer Kozak, Melissa Fleury, Paul R. Fatheree, Dante D. Podesto +1 more | 2021-09-07 |
| 11033533 | (2R,4R)-5-(5′-chloro-2′-fluorobiphenyl-4-yl)-2-hydroxy-4-[(5-methyloxazole-2-carbonyl)amino]pentanoic acid | Melissa Fleury, Adam D. Hughes, Erik Fenster, Venkat R. Thalladi, Miroslav Rapta | 2021-06-15 |
| 11008314 | Compounds and methods for modulating interleukin-2-inducible t-cell kinase | Ryan Hudson | 2021-05-18 |
| 10981892 | Acyl sulfonamides that are Bcl family antagonists for use in clinical management of conditions caused or mediated by senescent cells and for treating cancer | Ryan Hudson | 2021-04-20 |
| 10870652 | Compounds and methods for modulating bruton's tyrosine kinase | Ryan Hudson, Richard A. Miller, Erik Verner | 2020-12-22 |
| 10745429 | Phospholidines that are Bcl family antagonists for use in clinical management of conditions caused or mediated by senescent cells and for treating cancer | Ryan Hudson | 2020-08-18 |
| 10738042 | Phosphonamidates that are Bcl family antagonists for use in clinical management of conditions caused or mediated by senescent cells and for treating cancer | Ryan Hudson | 2020-08-11 |
| 10717722 | Acyl sulfonamides that are Bcl family antagonists for use in clinical management of conditions caused or mediated by senescent cells and for treating cancer | Ryan Hudson | 2020-07-21 |
| 10703745 | Acyl phosphonamidates and acyl benzylamines that are Bcl family antagonists for use in clinical management of conditions caused or mediated by senescent cells and for treating cancer | Ryan Hudson | 2020-07-07 |
| 10689416 | Peptide-based proteasome inhibitors for treating conditions mediated by senescent cells and for treating cancer | Ryan Hudson, F. Anthony Romero, Remi-Martin Laberge | 2020-06-23 |
| 10548879 | (2R,4R)-5-(5′-chloro-2′-fluorobiphenyl-4-yl)-2-hydroxy-4-[(5-methyloxazole-2-carbonyl)amino]pentanoic acid | Melissa Fleury, Adam D. Hughes, Erik Fenster, Venkat R. Thalladi, Miroslav Rapta | 2020-02-04 |
| 10526330 | JAK kinase inhibitor compounds for treatment of respiratory disease | Paul R. Fatheree, John R. Jacobsen, Gary E. L. Brandt, Melissa Fleury, Lan Jiang +3 more | 2020-01-07 |
| 10519197 | Peptide-based proteasome inhibitors for treating conditions mediated by senescent cells and for treating cancer | Ryan Hudson, F. Anthony Romero, Remi-Martin Laberge | 2019-12-31 |
| 10172834 | (2R,4R)-5-(5′-chloro-2′-fluorobiphenyl-4-yl)-2-hydroxy-4-[(5-methyloxazole-2-carbonyl)amino]pentanoic acid | Melissa Fleury, Adam D. Hughes, Erik Fenster, Venkat R. Thalladi, Miroslav Rapta | 2019-01-08 |
| 10100049 | JAK kinase inhibitor compounds for treatment of respiratory disease | Paul R. Fatheree, John R. Jacobsen, Gary E. L. Brandt, Melissa Fleury, Lan Jiang +3 more | 2018-10-16 |
| 10028960 | Pyrimidine compounds as JAK kinase inhibitors | Ryan Hudson, Jennifer Kozak, Melissa Fleury, Paul R. Fatheree, Dante D. Podesto | 2018-07-24 |